whatsNew_01

grantimage_300Announcing the 5th Annual DeGregorio Foundation Award for Cancers of the Esophagus and Stomach

The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce our 5th annual funding opportunity for gastroesophageal malignancies.  The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies.  We support high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.  Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.

Deadline: November 3, 2014. Up to $250,000 over two years will be awarded.  

Funding Period: January 1 2015- December 31, 2016

Amount: $250,000 for entire grant period. ($225,000 direct, $25,000 indirect).

Recent Advances in Research:

New view of stomach cancer could hasten better therapies

In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities. They say the new classification promises to advance clinical research to develop improved therapies for the third-leading cancer killer worldwide. Read more…

TCGA researchers identify four subtypes of stomach cancer

Stomach cancers fall into four distinct molecular subtypes researchers with The Cancer Genome Atlas (TCGA) Network have found. In the study, published online July 23, 2014, in Nature, the scientists report that this discovery could change how researchers think about developing treatments for stomach cancer, also called gastric cancers or gastric adenocarcinomas.

Instead of considering gastric cancer as a single disease, as has been done in the past, researchers will now be able to explore therapies in defined sets of patients whose tumors have specific genomic abnormalities. Stomach cancers are a leading cause of cancer-related mortality worldwide, resulting in an estimated 723,000 deaths annually. Read more…

upcoming_events

NYCM_logo_235

Team DeGregorio is participating in The TCS New York City Marathon!

Team DeGregorio is complete and 12 runners strong!  The race is in November 2, 2014 and training has begun. Please support our runners, who with their dedication, are helping us turn fact into fiction! See the current list of runners and make a donation.

Visit the official New York City Marathon site.

nyse_300savedate_230a

October 16, 2014

An Evening on the Trading Floor. Our Final Year at the New York Stock Exchange

The Benefit for Stomach & Esophageal Cancer Research

The DeGregorio Family Foundation and the Armstrong Family.

An Evening of Cocktails and Hors D’oeuvres.

New York Stock Exchange. 2 Broad Street New York, NY

 

our_mission

Learn more including the prevalence of, symptoms of, and risk factors for Esophageal Cancer.

Make a Donation. Support the DeGregorio Family Foundation

The DeGregorio Family Foundation supports research. Your gift will be used exclusively to support gastric and esophageal research and education. As an approved 501(c)(3) organization under the Internal Revenue code, gifts made to the foundation are tax deductible to the fullest extent of the law. Make a Donation and Support the Foundation »

Sign up for our Email Newsletter